The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

C R Bard Inc

NYSE: BCR
Last

(U.S.) $171.36

Today's change0.00 0.00%
Updated July 6 4:03 PM EDT. Delayed by at least 15 minutes.
 

C R Bard Inc

NYSE: BCR
Last

(U.S.) $171.36

Today's change0.00 0.00%
Updated July 6 4:03 PM EDT. Delayed by at least 15 minutes.

C R Bard Inc closed at (U.S.)$171.36.

This security is unchanged over the last five days and the last 52 weeks. This security has outperformed the S&P 500 by 13.41% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $171.36
  • High--
  • Low--
  • Bid / Ask(U.S.) $167.00 / (U.S.) $174.21
  • YTD % change+2.84%
  • Volume0
  • Average volume (10-day)375,968
  • Average volume (1-month)348,206
  • Average volume (3-month)469,716
  • 52-week range(U.S.) $141.49 to (U.S.) $180.94
  • Beta0.73
  • Trailing P/E47.11×
  • P/E 1 year forward19.00×
  • Forward PEG1.78×
  • Indicated annual dividend(U.S.) $0.96
  • Dividend yield0.56%
  • Trailing EPS(U.S.) $3.64
Updated July 6 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.55%

Based on its net profit margin of 8.55%, C R Bard Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue820867830827
Total other revenue--------
Total revenue820867830827
Gross profit509548521506
Total cost of revenue311320309321
Total operating expense624680638912
Selling / general / administrative236258242245
Research & development61797385
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)142515263
Other operating expenses, total2-2-1-2
Operating income196187192-85
Interest income (expense), net non-operating-11-11-11-11
Gain (loss) on sale of assets--------
Other--------
Income before tax185175180-93
Income after tax140134131-119
Income tax, total45414927
Net income140134131-119
Total adjustments to net income-2-2-20
Net income before extra. items140134131-119
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items138132129-119
Inc. avail. to common incl. extra. items138132129-119
Diluted net income138132129-119
Dilution adjustment--------
Diluted weighted average shares76777675
Diluted EPS excluding extraordinary itemsvalue per share1.821.721.69-1.59
Dividends per sharevalue per share0.220.220.220.21
Diluted normalized EPSvalue per share1.961.971.832.21